About QED Bioscience
QED Bioscience is a Healthcare company based in San Diego (United States) founded in 1997, and was acquired by Leinco Technologies in September 2024. Proteins and antibody reagents for research. The company has 6 employees. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is QED BIOSCIENCE, INC. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
QED Bioscience manufactures a wide range of monoclonal and polyclonal antibodies, recombinant proteins and assay kits for life science research. The company also provides custom antibody development, purification and production, and cell culture services.
- Headquarters San Diego, United States
- Employees 6
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website qedbio.com
- Social LinkedIn
- Acquired by Genovis (Feb 2020)
- Legal Name Qed Bioscience, Inc.
- InvestorsGenovis
& 1 more
- Employee Count6
- Acquired by
Investors in QED Bioscience
QED Bioscience has secured backing from 2 investors. Prominent investors backing the company include Genovis and Leinco Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Enzymes for monoclonal antibody characterization are developed. | 1999 | genovis.com | Lund, Sweden | |
Manufacturer of antibodies, proteins, reagents, and kits for life science research | 1992 | leinco.com | St. Louis, United States |
Investor details for QED Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of QED Bioscience
3 dated milestones of QED Bioscience across 27 years, from founding to its latest funding, stage changes and deals.
- Founded QED Bioscience is founded.
- Exit Acquired by Genovis.
- Exit Acquired by Leinco Technologies.
Competitors of QED Bioscience
QED Bioscience has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of QED Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of QED Bioscience
The website of QED Bioscience (qedbio.com) receives about 4.9K visits a month.
- Monthly visits4.9K
▲ 18.5% vs previous month
Websites whose visitors overlap most with QED Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 4adi.com | 100% | #3,842,387 | View details | ||
antibodyresource.com | antibodyresource.com | 92% | #6,501,729 | – | |
| antibodies-online.com | 92% | 57.4K | #648,443 | View details | |
liferesearch.com | liferesearch.com | 92% | – | ||
| yenzym.com | 92% | #6,477,156 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for QED Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as QED Bioscience (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Qed Bioscience
Complete news archive for QED Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QED Bioscience
QED Bioscience was founded in 1997.
QED Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
QED Bioscience has 6 employees.
QED Bioscience manufactures a wide range of monoclonal and polyclonal antibodies, recombinant proteins and assay kits for life science research. The company also provides custom antibody development, purification and production, and cell culture services.
QED Bioscience's top competitors include GenScript, Epitomics and Vector Laboratories.
QED Bioscience has 2 investors. Key investors include Genovis, and Leinco Technologies.
QED Bioscience operates through Qed Bioscience, Inc..
Yes. QED Bioscience was acquired by Genovis in February 2020.